# Non-interventional Study With Nab-Paclitaxel (Abraxane®)

> **NCT01689610** · — · COMPLETED · sponsor: **iOMEDICO AG** · enrollment: 705 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01689610
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-11
- **Final completion:** 2016-03
- **Target enrollment:** 705 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01689610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01689610, "Non-interventional Study With Nab-Paclitaxel (Abraxane®)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01689610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*